Skip to content

BIM Kemi increases prices for the tissue converting portfolio by up to 25%

Due to an extraordinary global supply situation resulting in force majeure declarations by raw material suppliers, BIM Kemi is forced to announce additional price increases on a wide range of tissue converting products by up to 25% depending on application.

BIM Kemi will continue to work in partnership with our customers to add value and optimise their processes to control the total cost efficiency.

For further information, please contact James Hudson, Tissue segment team leader, BIM Group

More news